The role of testing for BRCA1 and BRCA2 mutations in cancer prevention
- PMID: 24841841
- PMCID: PMC4169670
- DOI: 10.1001/jamainternmed.2014.1322
The role of testing for BRCA1 and BRCA2 mutations in cancer prevention
Conflict of interest statement
References
-
- Jolie A. My medical choice. [Accessed March 25, 2014];The New York Times. 2013 May 14; Opinion. http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html.
-
- Daly MB, Axilbund JE, Buys S, et al. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010;8(5):562–594. - PubMed
-
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med. 2014;160(4):255–266. - PubMed
-
- Sherkow JS, Greely HT. The future of gene patents and the implications for medicine. JAMA Intern Med. 2013;173(17):1569–1570. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous